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Spermidine synthase from rat ventral prostate was inhibited by 2-mercaptoethylamine (MEA). Inhibition of spermidine 
synthase by MEA was competitive with respect o one of the substrates putrescine, but not competitive with respect o 
the other substrate decarboxylated S-adenosylmethionine. MEA markedly depressed spermidine and spermine contents 
in human erythroid leukemia K562 cells, suggesting that these changes resulted from the inhibitory effect of MEA on 
spermidine synthase in situ. 
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1. INTRODUCTION 
Inhibitors of polyamine biosynthesis have 
become the subjects of intensive research because 
of their potential usefulness in the elucidation of 
the biological function of polyamines in cellular 
metabolism and in cell proliferation. Many com- 
pounds have been reported as inhibitors for or- 
nithine decarboxylase and S-adenosylmethionine 
decarboxylase [l]. Some of these compounds, 
however, have unwanted effects on cellular poly- 
amine metabolism, including stabilization and/or 
activation of these decarboxylases, paradoxical in- 
creases of the cellular concentrations of putrescine 
or spermine, inhibition of diamine oxidase, and 
other effects probably unrelated to polyamine 
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metabolism, for instance, mitochondrial damages 
[l-4]. It may therefore be of worth to find in- 
hibitors acting on the propylamine transferring 
steps and to develop agents of increased specifici- 
ty. Pegg and Hibasami [5] have pointed out that 
the limiting factor in spermidine and spermine syn- 
theses is the supply of one of their substrates decar- 
boxylated AdoMet. The intracellular concentra- 
tion of this substrate for spermidine and spermine 
synthases is very low and the turnover rates of 
these enzymes are relatively slow [6]. So these steps 
may well prove to be suitable sites at which poly- 
amine biosynthesis can be effectively inhibited. 
Hibasami and Pegg [7], and Pajula and Raina [S] 
have reported that MTA, a by-product of both 
spermidine and spermine synthase reactions, 
potentially inhibited spermine synthase. However, 
very little attention has been paid to 3-mercapto- 
propylamine moiety of decarboxylated AdoMet. 
Here we demonstrate that partially purified 
spermidine synthase from rat ventral prostate was 
inhibited by MEA, which has an analogous struc- 
ture to the 3-mercaptopropylamine moiety of 
decarboxylated AdoMet, and that addition of 
MEA to the culture medium caused a decrease in 
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the concentrations of spermidine and spermine in 
cultured human erythroid leukemia K562 cells. 
2. MATERIALS AND METHODS 
2.1. Chemicals 
MEA and MTA were purchased from Sigma, St. Louis, MO, 
USA. S-Adenosyl-L-[methyl-‘4C]methionine (53.6 mCi/mmol) 
was obtained from New England Nuclear, Boston, MA, USA. 
Decarboxylated AdoMet, both unlabelled and labelled in the 
methyl group were prepared by the action of S-adenosyl- 
methionine decarboxylase from Escherichia coli (strain B) and 
purified by chromatography on Dowex-50-H+ and paper elec- 
trophoresis as described [9]. All other chemicals were products 
of Nakarai Chemicals Ltd, Kyoto, Japan. 
2.2 Animals 
Male Wistar strain rats (250-300 g) were purchased from 
Shizuoka agricultural co-operative association for experimental 
animals, Hamamatsu, Japan. The animals were given’water and 
food ad libitum and ventral prostates were removed. 
2.3. Cell culture 
Human erythroid leukemia K562 cells were grown in RPM1 
1640 medium supplemented with 10% fetal calf serum, 
50 IU/ml penicillin G potassium and 50pg/ml streptomycin 
sulfate in a humidified chamber containing 5% CO2 in air at 
37°C. Cell number was measured by using counting chamber 
and microscope. Viability was determined by trypan blue stain- 
ing. 
2.4. Purification of spermidine and spermine synthases 
Spermidine and spermine synthases were purified from rat 
ventral prostate as described [lo]. Extracts containing both en- 
zyme activities were fractionated into spermidine synthase and 
spermine synthase preparations, respectively, by the treatment 
with ammonium sulfate followed by DEAE-cellulose and Ultra- 
gel ACA 43 column chromatography. The enzyme preparations 
used in this study were 265-fold (spermidine synthase) and 
170-fold (spermine synthase) of purification over the specific 
activity present in the crude ultracentrifugal extracts. These 
preparations of synthases were free from each other and neither 
preparation contained significant amounts of S-adenosyl- 
methionine decarboxylase or of 5 ‘-methylthioadenosine phos- 
phorylase. 
2.5. Assay for spermidine and spermine synthases 
The enzyme activities were determined by measuring the pro- 
duction of [methyl-%]methylthioadenosine from decarbox- 
ylated Sadenosyl-[methyl-‘4C]methionine in the presence of 
putrescine (spermidine synthase) or of spermidine (spermine 
synthase) as described [ll]. The assay mixture contained 
100 mM sodium phosphate buffer, pH 7.5, 5 mM dithio- 
threitol, 41.2 PM decarboxylated S-adenosyl-[methyl-‘4C]- 
methionine, 0.5 mM putrescine or 0.5 mM spermidine and the 
enzyme preparation in 0.1 ml of total volume unless otherwise 
noted. Assays were performed in triplicate incubating at 37’C 
for 30 min. The production of methylthioadenosine was entirely 
dependent on putrescine and spermidine. 
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2.6. Determination of intracellular polyamine contents 
Polyamines (putrescine, spermidine and spermine) were 
determined by HPLC as described [12]. K562 cells were 
harvested by low speed centrifugation (1000 x g for 3 min), 
suspended in ice-cold phosphate buffered saline and centrifuged 
once more. The resulting cell pellets were suspended in 0.4 N 
perchloric acid and disintegrated by freeze-thawing 3times. The 
samples were centrifuged at 10000 x g for 30 min, and the 
supernatants were analyzed by HPLC (Shimazu LC-SA). 
3. RESULTS AND DISCUSSION 
Fig.1 shows the dose-response curve for MEA 
on the inhibition of activities of spermidine and 
spermine synthases. Spermidine synthase was 
much more sensitive to MEA than spermine syn- 
thase. In table 1, the effects of MEA were com- 
pared with those of MTA. Unlike MEA, MTA 
inhibited spermidine synthase less sensitively than 
spermine synthase. It may be noteworthy that 
small molecules of MEA, which is analogous to the 
3-mercaptopropylamine moiety of decarboxylated 
AdoMet, retain an ability to inhibit spermidine 
synthase. On the other hand, 2-mercaptoethanol 
inhibited neither spermidine nor spermine syn- 
thases in the concentration range from 0.1 to 
1 mM (not shown), indicating that the amino 
group of MEA was necessary to inhibit the enzyme 
activity. 
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Fig.1. Inhibition of spermidine synthase (0) and spermine syn- 
thase (0) by MEA. The results are expressed as percentages of 
the control activity measured in the absence of MEA. Each 
point represents the mean of triplicate determinations. 
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Table 1 
Comparison of inhibition of spermidine and spermine synthases 
by MEA and MTA 
Compound Concentration Inhibition (Vo) 
(mM) Spermidine Spermine 
synthase synthase 
MEA 1 92.8 12.1 
0.1 66.5 1.4 
0.01 17.1 0.2 
MTA 0.1 76.7 91.6 
0.01 16.8 57.2 
MEA and MTA were tested by adding to the standard assay 
medium at the concentrations hown. Experimental details are 
given in section 2. The percentage inhibition due to the com- 
pounds are shown 
The observation that MEA was not able to 
stimulate [methyl-14C]methylthioadenosine pro- 
duction by spermidine or spermine synthases (not 
shown) indicated that MEA was not a substrate for 
the two synthases. 
Removal of MEA from the MEA-treated sper- 
, 
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Fig.2. Competitive inhibition of spermidine synthase by MEA 
with putrescine as the variable substrate. Spermidine synthase 
activity was assayed in the absence (0) or presence of 25 FM 
(0) or SO/M (A) MEA, with 41.2 PM decarboxylated 
AdoMet, 0.025-0.5 mM putrescine and an enzyme preparation. 
midine synthase preparation by dialysis restored 
the enzyme activity to that of the control enzyme 
preparation treated similarly except for exposure 
to the inhibitor. Thus, the inhibition of spermidine 
synthase by MEA was reversible. 
Fig.2 shows the effect of the concentration of 
putrescine on the inhibition of spermidine synthase 
by MEA. The inhibition was competitive with 
respect to putrescine. The Ki value for MEA and 
K,,, for putrescine were calculated to be 5 and 
36,~M, respectively. MEA may construct a 
homologous conformation to putrescine, resulting 
in competitive inhibition of spermidine synthase. 
Fig.3 shows the effect of the concentration of 
decarboxylated AdoMet on the inhibition of sper- 
midine synthase by MEA. Although the extent of 
inhibition by MEA increased as the concentration 
of the inhibitor was increased, spermidine synthase 
activity in the presence of MEA was apparently 
constant throughout the concentration range from 
8.2 to 82.4,uM of decarboxylated AdoMet. 
As shown in table 2, MEA dose-dependently 
depressed the spermidine and spermine contents in 
8- 
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Fig.3. Inhibition of spermidine synthase by MEA with decar- 
boxylated AdoMet as the variable substrate. Spermidine syn- 
thase activity was measured in the absence (0) or presence of 
25 PM (O), 50/M (A) or 100/1M (=) MEA, with 0.5 mM 
putrescine, 4.1-82.4/rM decarboxylated AdoMet and the en- 
zyme preparation. The insert shows the reciprocal plots of the 
experimental results. 
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